tm
Seeing Is Believing
tm
Seeing Is Believing
BHVN is currently covered by 13 analysts with an average price target of $137.83. This is a potential upside of $129.37 (1529.2%) from yesterday's end of day stock price of $8.46.
Biohaven Pharmaceutical Holding Co Ltd's activity chart (see below) currently has 313 price targets and 194 ratings on display. The stock rating distribution of BHVN is 78.13% BUY and 21.88% HOLD.
Analysts average stock forecasts to be materialized ratio is 28.43% with an average time for these price targets to be met of 747.11 days.
Highest price target for BHVN is $75, Lowest price target is $10, average price target is $25.5.
Most recent stock forecast was given by TYLER VAN BUREN from TD COWEN on 11-Mar-2026. First documented stock forecast 08-Jun-2018.
Currently out of the existing stock ratings of BHVN, 25 are a BUY (78.13%), 7 are a HOLD (21.88%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jun-2018
$30
$21.63 (258.42%)
$75
20 days ago
(11-Mar-2026)
3/17 (17.65%)
$19.54 (186.81%)
1348
Hold Since 03-Dec-2025
$10
$1.63 (19.47%)
$11
27 days ago
(04-Mar-2026)
4/18 (22.22%)
$-0.61 (-5.75%)
23
Buy Since 24-Jul-2024
$21
$12.63 (150.90%)
2 months 25 days ago
(06-Jan-2026)
0/6 (0%)
$11.38 (118.30%)
Hold Since 26-Nov-2025
$11
$2.63 (31.42%)
$26
4 months 5 days ago
(26-Nov-2025)
2/6 (33.33%)
$1.52 (16.03%)
26
Buy Since 04-Jan-2023
$15
$6.63 (79.21%)
$55
4 months 11 days ago
(20-Nov-2025)
7/13 (53.85%)
$5.37 (55.76%)
56
What is BHVN (Biohaven Pharmaceutical Holding Co Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on BHVN (Biohaven Pharmaceutical Holding Co Ltd) with a proven track record?
Which analyst has the most public recommendations on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
Which analyst is the currently most bullish on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
Which analyst is the currently most reserved on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
